Up­dat­ing the Covid-19 vac­cine: FDA of­fers a qual­i­fied thumbs-up ahead of ad­comm

The FDA’s ad­comm of out­side vac­cine ex­perts will meet to­mor­row to dis­cuss how to pro­tect the US from a like­ly com­ing wave of Omi­cron cas­es in the fall and win­ter, and whether to de­ploy vac­cines that specif­i­cal­ly tar­get the Omi­cron vari­ant.

While the da­ta so far are lim­it­ed, the FDA sound­ed an up­beat tone in the brief­ing doc­u­ments on Pfiz­er/BioN­Tech’s can­di­dates, re­leased this week­end ahead of the VRB­PAC meet­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER